Cite
HARVARD Citation
Nirogi, R. et al. (2021). Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders. Journal of psychopharmacology. pp. 713-729. [Online].